DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
Leflunomide Mylan ( DrugBank:
Leflunomide
)
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
53
シェーグレン症候群
1
53. シェーグレン症候群
臨床試験数
:
305
/
薬物数
:
325
- (
DrugBank
:
104
) /
標的遺伝子数
:
58
-
標的パスウェイ数
:
188
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
EUCTR2014-003140-12-NL
(
EUCTR
)
21/09/2015
26/08/2015
Leflunomide and Hydroxychloroquine combination therapy for primary Sjogren's Syndrome
Optimizing DMARD-therapy for primary Sjogren's Syndrome - Leflunomide and Hydroxychloroquine combination therapy for patients with primary Sjogren's Syndrome - LEF-HCQ combination therapy in pSS
Optimizing DMARD-therapy for primary Sjogren's Syndrome - Leflunomide and Hydroxychloroquine combina ...
Sjogren's Syndrome
MedDRA version: 18.0;Level: LLT;Classification code 10040766;Term: Sjogren's disease;System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
MedDRA version: 18.0;Level: PT;Classification code 10040767;Term: Sjogren's syndrome;Classification code 10042846;Term: Syndrome Sjogren's;Classification code 10040765;Term: Sjogren's;System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
Sjogren's Syndrome
MedDRA version: 18.0;Level: LLT;Classification code 10040766;Term: Sjogren's dise ...
Trade Name:
Leflunomide Mylan
Product Name:
Leflunomide mylan
INN or Proposed INN: LEFLUNOMIDE
Trade Name: Plaquenil
Product Name: Plaquenil
INN or Proposed INN: HYDROXYCHLOROQUINE
Trade Name:
Leflunomide Mylan
Product Name:
Leflunomide mylan
INN or Proposed INN: LEFLUNOMIDE
Trade Na ...
UMC Utrecht
NULL
Authorised-recruitment may be ongoing or finished
Female: yes
Male: no
Netherlands